These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10892199)

  • 1. [Economic analysis of therapeutic actions--fundamental concepts and examples of application].
    Shinbo T
    Nihon Naika Gakkai Zasshi; 2000 Jun; 89(6):1206-11. PubMed ID: 10892199
    [No Abstract]   [Full Text] [Related]  

  • 2. Health economics in technology development: is it worth it?
    Lee D
    J Nucl Med; 2008 Jun; 49(6):48N-50N. PubMed ID: 18511826
    [No Abstract]   [Full Text] [Related]  

  • 3. Future costs in economic evaluation. A comment on Lee.
    Feenstra TL; van Baal PH; Gandjour A; Brouwer WB
    J Health Econ; 2008 Dec; 27(6):1645-9; discussion 1650-1. PubMed ID: 18823670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics--what the nephrologist should know.
    Palmer AJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1038-41. PubMed ID: 15840678
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials and health economics--a marriage of convenience or a marriage made in heaven?
    Bakhai A; Greenberg D
    J Med Econ; 2008; 11(3):541-6. PubMed ID: 19450103
    [No Abstract]   [Full Text] [Related]  

  • 6. Health economics in public health.
    Ammerman AS; Farrelly MA; Cavallo DN; Ickes SB; Hoerger TJ
    Am J Prev Med; 2009 Mar; 36(3):273-5. PubMed ID: 19215853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic evaluation of therapeutic strategies. Finality, methods].
    Launois R
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():43-7. PubMed ID: 2512887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cost-benefit analysis of different therapeutic methods in menorrhagia].
    Kirschner R
    Tidsskr Nor Laegeforen; 1995 Feb; 115(5):618-21. PubMed ID: 7900119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
    Weintraub WS
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economics--concepts and conceptual problems.
    Satpathy SK; Bansal RD
    Health Popul Perspect Issues; 1982; 5(1):23-33. PubMed ID: 10310083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-cost and cost-effectiveness analysis: theory and application.
    McCarthy NJ
    Dev Biol Stand; 1979; 43():403-17. PubMed ID: 118068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
    Kymes SM
    Ophthalmic Epidemiol; 2008; 15(2):76-83. PubMed ID: 18432490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficiency-based healthcare. General concepts on economic evaluation of healthcare interventions].
    Catalá-López F
    Enferm Clin; 2009; 19(1):35-42. PubMed ID: 19233020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An introduction to the medical economics: cost-benefit analysis in medicine].
    Sakamoto Y
    Hinyokika Kiyo; 1987 Oct; 33(10):1518-22. PubMed ID: 3128065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?].
    Triomphe A
    Diabete Metab; 1993 Dec; 19(5 Suppl):473-6. PubMed ID: 8206181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation for ophthalmologists.
    Kuper H; Jofre-Bonet M; Gilbert C
    Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
    Knudsen AB; McMahon PM; Gazelle GS
    J Clin Oncol; 2007 Jan; 25(2):203-8. PubMed ID: 17210941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic evaluations more and more important in healthcare decision making. Costs must be balanced against benefits also in studies on health economics].
    Lundkvist J
    Lakartidningen; 2006 Nov 15-21; 103(46):3624-7. PubMed ID: 17153872
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation of health care interventions: an economist's perspective.
    Gafni A
    ACP J Club; 1996; 124(2):A12-4. PubMed ID: 8963522
    [No Abstract]   [Full Text] [Related]  

  • 20. An economic perspective on the cost of disease.
    Tjiptoherijanto P
    Southeast Asian J Trop Med Public Health; 1986 Sep; 17(3):489-95. PubMed ID: 3105088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.